Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma
- Hemant K. Bid
- , Aaron Kibler
- , Doris A. Phelps
- , Sagymbek Manap
- , Linlin Xiao
- , Jiayuh Lin
- , David Capper
- , Duane Oswald
- , Brian Geier
- , Mariko DeWire
- , Paul D. Smith
- , Raushan T. Kurmasheva
- , Xiaokui Mo
- , Soledad Fernandez
- , Peter J. Houghton
Research output: Contribution to journal › Article › peer-review
54
Link opens in a new tab
Scopus
citations